PortfoliosLab logoPortfoliosLab logo
XBI vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XBI vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Biotech ETF (XBI) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XBI achieves a 9.42% return, which is significantly higher than XLVI's 1.35% return.


XBI

1D
2.77%
1M
-0.28%
YTD
9.42%
6M
8.61%
1Y
62.35%
3Y*
15.65%
5Y*
1.14%
10Y*
8.53%

XLVI

1D
2.03%
1M
4.01%
YTD
1.35%
6M
3.19%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

XBI vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between XBI and XLVI is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.53

XBI vs. XLVI - Sectors Allocation Comparison


Sectors
XBI
XLVI

Healthcare

99.8%

-

Financial Services

0.2%
100.6%

Basic Materials

0.2%

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XBI
99.8%
XLVI

-

Financial Services

XBI
0.2%
XLVI
100.6%

Basic Materials

XBI
0.2%
XLVI

-

Communication Services

XBI

-

XLVI

-

Consumer Cyclical

XBI

-

XLVI

-

Consumer Defensive

XBI

-

XLVI

-

Energy

XBI

-

XLVI

-

Industrials

XBI

-

XLVI

-

Real Estate

XBI

-

XLVI

-

Technology

XBI

-

XLVI

-

Utilities

XBI

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XBI vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBI
XBI Risk / Return Rank: 8080
Overall Rank
XBI Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 7575
Sortino Ratio Rank
XBI Omega Ratio Rank: 6767
Omega Ratio Rank
XBI Calmar Ratio Rank: 9393
Calmar Ratio Rank
XBI Martin Ratio Rank: 8989
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBI vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XBIXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.40

Calmar ratioReturn relative to maximum drawdown

6.45

Martin ratioReturn relative to average drawdown

19.53

XBI vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


XBIXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.45

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

1.54

-1.18

Drawdowns

XBI vs. XLVI - Drawdown Comparison

The maximum XBI drawdown since its inception was -63.89%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for XBI and XLVI.


Loading charts...

Drawdown Indicators


XBIXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-63.89%

-8.14%

-55.75%

Max Drawdown (1Y)

Largest decline over 1 year

-9.72%

Max Drawdown (3Y)

Largest decline over 3 years

-32.99%

Max Drawdown (5Y)

Largest decline over 5 years

-54.71%

Max Drawdown (10Y)

Largest decline over 10 years

-63.89%

Current Drawdown

Current decline from peak

-22.89%

-2.08%

-20.81%

Average Drawdown

Average peak-to-trough decline

-20.93%

-1.95%

-18.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.20%

Volatility

XBI vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


XBIXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.69%

Volatility (6M)

Calculated over the trailing 6-month period

20.31%

Volatility (1Y)

Calculated over the trailing 1-year period

25.60%

11.12%

+14.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.20%

11.12%

+21.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.00%

11.12%

+20.88%

XBI vs. XLVI - Expense Ratio Comparison

Both XBI and XLVI have an expense ratio of 0.35%.


Dividends

XBI vs. XLVI - Dividend Comparison

XBI's dividend yield for the trailing twelve months is around 0.33%, less than XLVI's 11.30% yield.


PositionTTM20252024202320222021202020192018201720162015
XBI
SPDR S&P Biotech ETF
0.33%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.30%5.73%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


XBI and XLVI have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

XBI and XLVI have the same expense ratio: 0.35% per year.

XLVI has the higher dividend yield at 11.30%, compared with 0.33% for XBI.

XBI is categorized as Health & Biotech Equities, while XLVI is Derivative Income.

Portfolio Optimizer

Find the right allocation for XBI and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer